|Podcasts|April 21, 2011

Global Regulatory Capacity

Global Regulatory Capacity

Paul Pomerantz, Worldwide Executive Director of the Drug Information Association, discusses the issues taxing regulatory agencies worldwide as well as clinical trial complexity, lack of global harmonization, regulatory workload and more.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Articles

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast
May 2nd 2025
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025
Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling and Simulation Technologies Can Improve Drug Development
January 6th 2023
The Evolving Relationship Between Sponsors and the Contract Research Organizations
December 8th 2022
The MDR: Navigating Europe’s New Standard for Medical Device Safety
October 25th 2022
The impact an eClinical Supply Chain Management platform can have on your next clinical trial
September 19th 2022

Trending on Applied Clinical Trials Online

Generative AI Transforms Clinical Study Report Development

Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success

IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes

Everything to Know About FDA’s Push Towards Radical Transparency in 2025

Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19

© 2025 MJH Life Sciences^®

All rights reserved.